10-sec Recap: Research in 2025 and 2026 suggests that GLP-1 receptor agonists (like semaglutide) can reduce cravings for alcohol, opioids, and nicotine. It works by targeting the brain’s reward centers. These medications might help patients maintain sobriety as long as they stay on the medication. At Milestone Treatment Center, we stay at the forefront of these evidence-based recovery options. Keep reading to learn more about GLP-1s for substance use disorder (SUD), alcohol use disorder (AUD), and answers to some common questions.
What is the Difference Between GLP-1 and GLP-1 Agonists?
GLP-1 and GLP-1A are not the same thing despite similar names. It is important to distinguish between the natural hormone and the medication. Natural GLP-1 is a gut hormone that regulates blood sugar but only lasts about two minutes in the body. In contrast, GLP-1 agonists (GLP-1A) are synthetic versions designed to last much longer: from hours to an entire week.
| Feature | GLP-1 (Natural Hormone) | GLP-1 Agonists (Medication) |
|---|---|---|
| Origin | Produced in the intestines | Lab created analogs |
| Lifespan | 1–2 minutes | Up to 1 week (e.g., semaglutide) |
| Effect on Addiction | Brief physiological signals | Sustained brain receptor activation |
How GLP-1 Medications Impact the Brain
Within the scope of addiction treatment and care, GLP-1RAs act on the mesolimbic reward system. This is the area of the brain responsible for “cravings.” By acting on the nucleus accumbens, these drugs dampen the dopamine surges triggered by drugs or alcohol. You don’t need to know all this anatomy and physiology to use these medications, but it’s important to know how it may work in you or your loved one’s body.
Unlike some older medications, these agonists provide the sustained activation needed for real behavioral change. They essentially curb the “reward” the brain feels from substance use, making it easier for patients to focus on their recovery journey.
New Evidence for Alcohol Use Disorder (AUD)
A clinical trial in 2025 found that low-dose semaglutide significantly reduced alcohol consumption. Patients reported fewer drinks per day and lower craving scores over a nine-week period. Data from the VA also shows that semaglutide users had a 56% lower risk of developing alcohol use disorder compared to those on other medications.
This is a major breakthrough for harm reduction. Because these medications work passively to cut intake, they offer hope to those who struggle with traditional willpower-based methods.
Expanding Potential: Opioids, Nicotine, and Stimulants
The benefits of GLP-1RAs may extend to other substances:
- Opioids: Early data suggests semaglutide could cut overdose risk by 40% in certain patients.
- Nicotine: Animal studies show these medications blunt withdrawal symptoms and reduce self-administration.
- Stimulants: New trials are testing tirzepatide for its ability to reduce stimulant use.
Is Treatment Affordable?
At Milestone Treatment Center, we believe financial stress shouldn’t block your path to recovery. While we do not accept Medicare or Medicaid, we work with most private insurance providers. Our team works hard to ensure your treatment is covered so you can focus entirely on getting well.
You don’t have to figure this out alone.
Call our 24/7 line right now — someone kind is waiting: 856.754.5048
Safety and the Future of Recovery
While promising, these medications are not yet FDA-approved specifically for addiction. Common side effects include mild nausea and weight loss. It is vital to use these tools under the supervision of medical experts who understand the nuances of addiction medicine. If appropriate, our clinician are able to prescribe GLP-1 antagonists for addiction treatment.
Milestone Treatment Center provides expert care in Merchantville, NJ and Virginia Beach, VA, while serving families nationwide. We combine the latest medical research with compassionate, human-led therapy.
Frequently Asked Questions
Are GLP-1 medications like Ozempic FDA-approved for addiction?
Currently, these medications are FDA-approved for type 2 diabetes and weight management. Use for addiction is considered “off-label,” but clinical trials are rapidly showing they can significantly reduce cravings for alcohol and opioids. Always consult our clinical team before starting any new medication protocol.
How do these drugs help with alcohol and drug cravings?
GLP-1 agonists target the brain’s mesolimbic reward system—the area responsible for the “high” and subsequent cravings. By dampening these dopamine surges, the medication makes it easier to resist the urge to use while you participate in therapy.
Does insurance cover addiction treatment at Milestone?
We work exclusively with private insurance providers to ensure our clients receive the high-quality care they deserve. While we do not accept Medicare or Medicaid, our team handles the heavy lifting of insurance verification so you can focus on your recovery without financial worry.
Why is “Human Insight” important if I am using medication for recovery?
Medication is a powerful tool, but it is not a replacement for professional guidance. At Milestone, we combine medical advancements with real human experience and editing to ensure your treatment plan is accurate, safe, and tailored to your specific life story.
Do you offer treatment for residents in New Jersey and Virginia?
Yes. We have physical locations in Merchantville, NJ and Virginia Beach, VA, and we provide expert addiction services to clients across the nation. Our goal is to make recovery accessible and straightforward for every family we serve.
